PROMISE (Placental malaria: Recognition Of host potential biomarkers associated with the dISEase)
Not Applicable
Not yet recruiting
- Conditions
- Malaria
- Registration Number
- PACTR202407739257214
- Lead Sponsor
- Clinical Research Unit of Nanoro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Only samples that meet the following criteria will be included in the current study:
-The donor pregnant woman signed an informed consent authorizing the further use of their samples in studies of malaria and other infectious diseases.
-Availability of subsequent samples from the same individual at Days 0, 28, 63;
Exclusion Criteria
-Absence of clinical data related to the samples;
-Absence of placenta biopsy for analysis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What host biomarkers are being investigated in the PROMISE trial for placental malaria disease association?
How does the PROMISE trial approach compare to standard-of-care treatments for placental malaria in terms of effectiveness?
What molecular mechanisms underlie placental malaria pathogenesis as studied in the PROMISE trial?
Are there potential adverse events associated with the PROMISE trial's interventions and how are they managed?
What related compounds or combination therapies are being explored alongside the PROMISE trial for placental malaria?